|
Columbia Laboratories' mission is to build a specialty women's healthcare business with a competitive advantage in the United States. We promote four prescription pharmaceutical products in the U.S., including CRINONE® 8% and PROCHIEVE® 8% progesterone gels, two brands of our bioadhesive natural progesterone vaginal gel used as part of an Assisted Reproductive Technology treatment for infertility and pregnancy support. We derive additional revenues through marketing agreements for four other products. We are building shareholder value by driving prescription growth of our infertility products. We also seek opportunities to expand our product base and thereby leverage our sales force; to develop new products using our drug delivery technology for Columbia or partners; and to partner or divest products that fall outside our core women’s healthcare focus.
|
|